In the last 10 years, 15% of diabetics have been added, eventually increasing


Update: 11.7.2018 18:21

Prague – In the last ten years, 15% of diabetics have been treated, nearly 930,000 last year. Other people do not yet know their diagnosis. The treatment of these patients is approximately 13% of the total healthcare costs, on average 53,000 kronor per patient. Today's information was given at a press conference of the Czech Association of Pharmaceutical Companies (ČAFF) on the World Diabetes Day, which is celebrated on November 14th.

About 90 percent of diabetics have diabetes of another type, which is half genetically conditioned and the other half forms an unhealthy way of life. On the head of Diabetes Diabetes, Marty Klement's diabetes, 30 minutes of exercise, including walking or horticulture, reduces the risk of diabetes by as much as a third.

For Type 2 diabetes, the body has an insulin surplus that can not be released as soon as the patient needs it. In addition, their own insulin does not work the way it is, and it's called insulin resistance.

Last year, approximately 33 billion crowns were earmarked for the treatment of second-grade diabetes in the Czech Republic, along with some 300 billion health services. If the number of diabetics has increased at the same rate as before, in 2035 every ten Chekhov will suffer. "Permanent growth will eventually become unrealistic," added Clement.

Patients usually take a combination of up to four medications for diabetes, another for blood pressure or high cholesterol. "Patients are not treated with a combination of ten medicines, because if they do not follow the diet, their glycemia will not be standard," said Clement, who said that the cost of working with the patient and his lifestyle is much lower and often more effective than treatment. More than a third do not follow medical treatment.

The Czech Society for Diabetes supports patient education. Studies show that group therapies are even more effective than individuals who are talking to a patient. According to Clement, health insurance companies will also pay from next year. "The problem is that patients get it, but if they come back, they return more often than regular reviews," she added.

A patient who changes his lifestyle can achieve such an improvement that he will not need to take as many medicines as he can and be cheaper for the health system. Martin Mátl, director of CAFF, is also working to solve the costs of public health insurance by introducing so-called generic medicines, a copy of the original medicines that ended patent protection. An example is merformin, which is used by most diabetics. In the last ten years, according to Math, generic savings of 3.7 billion crowns.

In addition, diabetics do not only treat symptoms that are directly related to diabetes, but more often suffer from chronic complications such as heart disease and renal failure. The risk of a stroke increases the diabetes by two to four times, a five-fold infarction, heart failure, or coronary artery disease.





Source link